Publications by authors named "J Kopycinski"

Claim this Profile
A
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical Lesions.
Karin Hellner, Philippe Simon, Philippe De Sutter, Kadri-Liina Vahula, Paula Briggs, Jakub Kopycinski

Clin Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB.
Won Young Tak, Wan-Lobg Chuang, Chi-Yi Chen, Kuo-Chih Tseng, Young-Suk Lim, Jakub Kopycinski

J Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV.
Charlotte Davis, Dave Singh, Katie Anderson, Antonella Vardeu, Jakub Kopycinski

Vaccines (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.
Jakub Kopycinski, Hongbing Yang, Gemma Hancock, Matthew Pace, Ellen Kim

Sci Rep· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrawide Dark Solitons and Droplet-Soliton Coexistence in a Dipolar Bose Gas with Strong Contact Interactions.
Jakub Kopyciński, Maciej Łebek, Wojciech Górecki, Krzysztof Pawłowski

Phys Rev Lett· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis